Cosmos Health Inc. · NASDAQ:COSM

Cosmos Health Inc. financial statements

Cosmos Health Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue65.3M54.4M53.4M50.3M56.2M55.4M39.7M37.1M30.0M6.76M
Cost of revenue57.4M50.1M49.0M44.4M47.9M47.3M36.0M34.7M28.1M6.15M
Gross profit7.90M4.31M4.35M5.96M8.33M8.06M3.66M2.41M1.96M601.0K
Research and development519.4K533.3K164.9K000
Selling, general and administrative22.4M11.7M25.4M12.6M11.7M4.19M3.29M3.59M4.85M794.1K
Operating income-16.7M-15.5M-21.8M-7.47M-4.53M2.71M-255.8K-1.23M-4.87M-202.5K
Depreciation and amortization1.36M1.22M614.4K103.2K352.4K397.6K394.6K43.9K17.4K9.45K
EBITDA-15.3M-14.3M-21.2M-7.37M-4.18M3.11M138.8K-1.18M-4.85M-193.1K
Interest expense1.90M1.01M866.5K2.35M2.82M2.76M-1.41M-967.8K748.5K189.7K
Income before tax-19.1M-16.2M-18.5M-13.1M-7.85M1.20M-3.12M-9.04M-6.21M-600.2K
Income tax000-775.1K114.0K-377.5K182.8K-17.3K2.80K769
Net income-19.1M-16.2M-18.5M-13.8M-7.96M820.8K-3.30M-9.06M-6.21M-601.0K
Earnings per share, basic-0.63-1.17-2.15-33.16-23.740.06-0.25-0.68-0.490.00
Earnings per share, diluted-0.63-1.17-2.15-33.16-23.740.06-0.25-0.68-0.4980,741.00

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents715.7K315.1K3.83M20.7M286.5K628.4K38.5K864.3K782.9K716.6K
Short-term investments46.2K21.1K20.1K14.9K11.5K222.8K238.9K2.71M00
Receivables19.6M13.5M19.8M23.7M30.1M26.9M9.27M4.75M1.26M661.9K
Inventory5.78M4.36M4.79M3.45M3.15M3.29M3.47M3.20M3.09M464.2K
Current assets38.4M25.5M36.6M56.4M39.8M40.8M21.2M18.3M9.51M2.64M
Property, plant and equipment10.6M9.69M10.3M1.82M1.89M1.76M1.73M1.43M114.6K52.7K
Goodwill49.7K49.7K49.7K49.7K49.7K49.7K49.7K49.7K1.95M0
Total assets65.5M54.3M66.0M68.0M49.4M43.8M23.9M20.7M10.7M3.12M
Accounts payable14.6M11.2M11.9M10.3M12.1M12.0M8.00M9.80M9.95M2.87M
Current liabilities38.3M25.8M24.3M21.7M29.9M34.3M28.2M22.3M13.7M4.87M
Long-term debt5.85M1.56M1.33M2.86M477.6K10.8M1.55M00
Total debt3.78M4.11M4.61M5.02M17.9M10.8M0145.5K10.2M3.20M
Total liabilities47.1M29.8M30.0M28.4M45.0M48.0M30.3M24.0M13.7M4.87M
Shareholders' equity18.4M24.5M36.0M39.3M4.38M-4.16M-6.46M-3.32M-3.03M-1.75M
Shares outstanding41.1M23.6M15.9M10.6M686.3K13.1M12.9M13.7M12.7M12.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.45M-7.72M-15.6M-14.9M-7.10M-11.5M-4.79M-1.56M-8.76M-2.13M
Capital spending-55.7K-418.1K-1.31M-74.2K-581.4K-117.7K-672.8K-503.4K-55.3K-12.8K
Free cash flow-8.50M-8.14M-16.9M-14.9M-7.68M-11.6M-5.46M-2.06M-8.82M-2.14M
Cash from investing-2.01M-798.3K-13.8M-21.5K-826.8K-117.7K588.9K-195.8K-14.5K-144.7K
Cash from financing14.1M5.05M12.7M35.0M7.27M12.5M3.59M1.99M9.29M2.74M
Dividends paid-6.20M-32.0M-7.63M000
Share buybacks0-100.5K-376.9K-376.9K-200.0K-845.2K-80.1K-34.5K0
Change in cash3.14M-3.52M-16.9M20.5M-341.9K589.9K-825.8K81.5K66.3K518.5K